Breadcrumb
Presentation Materials
Effectiveness and safety of empagliflozin in routine care: results from the empagliflozin comparative effectiveness and safety (EMPRISE) study
Material Type: Poster
The renal and vascular effects of combined SGLT2 and angiotensin converting enzyme inhibition
Material Type: Presentation
Cardiovascular effectiveness of empagliflozin vs glucagon-like peptide-1 receptor agonists or liraglutide in the EMPRISE study
CV risk factor control in patients with T2D and CAD vs stroke
Diabetes study of linagliptin and empagliflozin in children and adolescents with type 2 diabetes
Favorable kidney outcomes are associated with empagliflozin vs DPP-4i therapy in patients with diabetes and normal kidney function
